CRMD: Kapitalisasi marang bathi resik kanthi nimbang wutah CorMedix Inc.

Simbol lan logo merek CorMedix Therapeutics (CRMD)

The valuation-to-earnings growth ratio reflects market sentiment, with the indicator currently at 0.00. CorMedix Inc. (CRMD) has solidified a positive image thanks to the success of Defencath. The brand is renowned for developing innovative tools to protect dialysis patients. The product's uniqueness in combating catheter-related infections has secured the company a protected niche within therapeutic centers.

CRMD (cormedix.com) riwayat Pangali PEG saka 04.07.2022 nganti 12.11.2026

Rincian analitis perusahaan CorMedix Inc. (CRMD)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega CorMedix Inc|CRMD - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Kapitalisasi pasar CorMedix Corp|CRMD - Nilai Total Perusahaan
- rincian nilai buku perusahaan:
Ekuitas saben Saham CorMedix|CRMD - Kapitalisasi Buku|Kapitalisasi Pasar marang Aset Bersih cormedix.com|CRMD - Total Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal CorMedix Inc.|CRMD - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas cormedix.com|CRMD - Gunggung utang perusahaan|Utang marang modal buku CorMedix Corp|CRMD - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak CorMedix|Likuiditas darurat cormedix.com
- indikator pendapatan resik lan kelipatan nilai:
CRMD - Bathi resik perusahaan|Prakiraan bathi resik CorMedix Inc.|CRMD - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi CorMedix Therapeutics|CRMD - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CorMedix Corp|CRMD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan CorMedix|CRMD - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan cormedix.com|CRMD - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep CorMedix Inc.
Ringkesan analitik perusahaan:CorMedix Inc
Produk seri CorMedix

Strategic alliances between CorMedix Inc. (CRMD) and dialysis centers to implement antimicrobial systems create a foundation for scaling, which is reflected in the company's P/E ratio and growth rates. This indicator divides the price-to-earnings ratio by the annual earnings growth percentage: a value below one signals that the asset is undervalued relative to its momentum, providing the investor with a significant margin of safety upon purchase.

Perusahaan pesaing

SMMT (Summit Therapeutics plc) - Koefisien bali modal nimbang wutah|Pangali PEG MRNA (Moderna Corp)|Kapitalisasi marang bathi resik kanthi nimbang wutah SutroVax (PCVX)|TARS - Rasio rega marang bathi tumrap wutah|MCRB (serestherapeutics.com) - Rasio P/E diaturake wutah|SPRO: Pangali PEG|Rasio kapitalisasi marang bathi lan wutah SCYX (SCYNEXIS)|ANTX (AN2 Therapeutics Inc) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah PolyPid Limited PYPD|Pangali PEG LSB|Pangali rega marang bathi tumrap wutah iterumtx.com ITRM|BiomX - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi SNGX (Soligenix Inc)|60 Degrees Pharma - Pangali PEG|Kapitalisasi marang bathi resik kanthi nimbang wutah Oragenics Inc. OGEN|OpGen, Inc. (OPGN) - Rasio rega marang bathi tumrap wutah